{"nct_id":"NCT07005128","title":"A Study Comparing Tarlatamab, Durvalumab, Carboplatin, and Etoposide Versus Durvalumab, Carboplatin, and Etoposide in First-line Extensive Stage Small-Cell Lung Cancer (ES-SCLC)","status":"RECRUITING","status_verified_date":"2025-09","start_date":"2025-08-18","start_date_type":"ACTUAL","primary_completion_date":"2029-01-04","primary_completion_date_type":"ESTIMATED","completion_date":"2029-07-15","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["AMGN"]}